A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors
Crossref DOI link: https://doi.org/10.1007/s00280-014-2647-x
Published Online: 2014-12-20
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Uronis, Hope E.
Jia, Jingquan
Bendell, Johanna C.
Howard, Leigh
Ready, Neal A.
Lee, Paula H.
Starr, Mark D.
Dellinger, Andrew
Pang, Herbert
Nixon, Andrew B.
Hurwitz, Herbert I.
Text and Data Mining valid from 2014-12-20